Literature DB >> 31394198

Spatial and temporal immunoreactivity in the rat brain using an affinity purified polyclonal antibody to DNSP-11.

James W H Sonne1, Jason S Groshong2, Corey Seavey2, Don M Gash3.   

Abstract

DNSP-11 antibody signal was investigated in perfusion fixated Fischer 344 rat brains by immunohistochemistry with a custom, affinity purified polyclonal antibody. The DNSP-11-antibody signal was differentially localized from the mature GDNF protein both spatially and temporally. In the mesencephalon of post-natal day 10 animals, when GDNF is maximally expressed, DNSP-11 and GDNF antibody immunoreactivities co-localize extensively but not exclusively. In adult 3-month-old animals, GDNF expression is markedly reduced while the DNSP-11 signal remains intense. DNSP-11-antibody signal was present in the 3-month-old rat brain with signal in the substantia nigra, ventral tegmental area, dentate gyrus of the hippocampus, with the strongest signal observed in the locus ceruleus where GDNF is not expressed. While amino acid sequence homologues such as NPY and Tfg do exist, binding patterns reported in the literature of do not recapitulate the immunoreactive patterns observed for the DNSP-11-antibody signal.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNSP-11; GDNF; Locus ceruleus; Parkinson’s disease; Substantia nigra

Mesh:

Substances:

Year:  2019        PMID: 31394198      PMCID: PMC6745710          DOI: 10.1016/j.jchemneu.2019.101664

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  62 in total

Review 1.  Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B.

Authors:  W Tatton; R Chalmers-Redman; N Tatton
Journal:  J Neural Transm (Vienna)       Date:  2003-05       Impact factor: 3.575

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer.

Authors:  G W Carlile; R M Chalmers-Redman; N A Tatton; A Pong; K E Borden; W G Tatton
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

4.  Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.

Authors:  Ana P Silva; Arsélio P Carvalho; Caetana M Carvalho; João O Malva
Journal:  Neuropharmacology       Date:  2003-02       Impact factor: 5.250

Review 5.  Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling.

Authors:  W G Tatton; R M Chalmers-Redman; M Elstner; W Leesch; F B Jagodzinski; D P Stupak; M M Sugrue; N A Tatton
Journal:  J Neural Transm Suppl       Date:  2000

6.  Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices.

Authors:  M W Ho; A G Beck-Sickinger; W F Colmers
Journal:  J Neurophysiol       Date:  2000-02       Impact factor: 2.714

7.  Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease.

Authors:  N A Tatton
Journal:  Exp Neurol       Date:  2000-11       Impact factor: 5.330

8.  Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys.

Authors:  Richard Grondin; Zhiming Zhang; Ai Yi; Wayne A Cass; Navin Maswood; Anders H Andersen; Dennis D Elsberry; Michael C Klein; Greg A Gerhardt; Don M Gash
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

9.  Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures.

Authors:  Ana P Silva; Paulo S Pinheiro; Arsélio P Carvalho; Caetana M Carvalho; Birthe Jakobsen; Jens Zimmer; João O Malva
Journal:  FASEB J       Date:  2003-04-08       Impact factor: 5.191

10.  Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases.

Authors:  Chris Zarow; Scott A Lyness; James A Mortimer; Helena C Chui
Journal:  Arch Neurol       Date:  2003-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.